←
Richard J. Kuhn146 posts
Richard J. Kuhn avatar

Richard J. Kuhn

@DirectorPI4D

Anderson Distinguished Professor in Science; Krenicki Director in Inflammation, Immunology and Infectious Disease at Purdue University; Editor in Chief,Virology

◷ Joined December 2017▧ 6 Photos and videos
Kellie Ann Jurado avatar
⟳ Richard J. Kuhn retweeted
Kellie Ann Jurado@kelliejurado·28 Oct 2022

It was at my first @sacnas as an undergrad that solidified my decision to pursue science as a career. To come back as an independent scientist w/ that seemingly impossible goal realized is astounding & feel so honored to be back encouraging others to go forward w/their dreams!

Post attachment
Florian Krammer avatar
⟳ Richard J. Kuhn retweeted
Florian Krammer@florian_krammer·6 Aug 2022

This is just nuts. I was not aware that the rate of kids not protected against polio in NYC is that high. Vaccination rates should be close to 100%.

Our new map shows polio vaccination rates for NYC children 6 months to 5 years old. According to our data, 13.8% have not been vaccinated against polio. Polio is highly contagious. The most important way to prevent polio is by getting vaccinated: on.nyc.gov/polio

Post attachment
Jon Cooper 🇺🇸 avatar
⟳ Richard J. Kuhn retweeted
Jon Cooper 🇺🇸@joncoopertweets·21 Jul 2022

BREAKING: The first US polio case in over 9 years happened because they were not vaccinated. They now have paralysis. I don't know who needs to hear this right now, but vaccines work.

Ana Fernandez-Sesma avatar
⟳ Richard J. Kuhn retweeted
Ana Fernandez-Sesma@SesmaLab·29 Apr 2022

Good start of the day. @theNASciences fir the 2019, 2020 & 2021 new members’ induction ceremony, surrounded by Rock Stars like Karla Kirkegaard, Peter Sarnow, @HarmitMalik and Adolfo Garcia-Sastre🤩🤩🤩🤩. Not too shabby

Post attachmentPost attachmentPost attachmentPost attachment
Matthew R. Vogt avatar
⟳ Richard J. Kuhn retweeted
Matthew R. Vogt@VogtVirusLab·25 Mar 2022

Hard to believe our lab reached this point already and super stoked to have hit this milestone. We have our first R01! Vogt Wins $3.1M NIAID Grant to Develop New Monoclonal Antibodies news.unchealthcare.org/2022/…

Erica OllmannSaphire avatar
⟳ Richard J. Kuhn retweeted
Erica OllmannSaphire@EOSaphire·5 Mar 2022

LCMV has been a beacon illuminating immunobiology for 50+ years but the CD164 entry factor remained unknown… until now. Hot off the @PNASNews presses from @glycobrotein @vsv512 and friends.

This tweet is unavailable

Jose Lab avatar
⟳ Richard J. Kuhn retweeted
Jose Lab@joselab_psu·25 Feb 2022

Presenting our first SARS-CoV-2 antiviral paper! We introduce a live-cell imaging-based in-cell protease assay to screen inhibitors for SARS-CoV-2. Crystal structure shows the inhibitor bound at the protease active site nature.com/articles/s42003-0…

Kartik Chandran avatar
⟳ Richard J. Kuhn retweeted
Kartik Chandran@ChandranLab·10 Feb 2022

Thank you to @cellhostmicrobe for featuring our work on the vaccine-induced neutralizing antibody response against yellow fever virus and to @croweje and @RHCarnahan for their thoughtful perspective (below).

Even old foes can learn sweet new tricks: @RHCarnahan @croweje discuss @HaslwanterD @ChandranLab work investigating 17D #YellowFever virus vaccine neutralization of 17D & African strains vs. contemporary Central/South American strains, including YFV ES-504 cell.com/cell-host-microbe/f…

Post attachment